Pharmacokinetics of Continuous Infusion Fentanyl in Cancer Patients
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Baltimore |
| State: |
|
Maryland |
| Zip Code: |
|
21231 |
| Conditions: |
|
Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pa |
| Purpose: |
|
RATIONALE: Studying blood samples from cancer patients undergoing pain treatment in the
laboratory may help doctors learn more about how pain drugs work in the body. It may also
help doctors predict how patients will respond to treatment.
PURPOSE: This research study is looking at fentanyl in patients with cancer.
|
| Study Summary: |
|
OBJECTIVES:
- To describe the pharmacokinetics of prolonged intravenous infusions of fentanyl citrate
in adult patients with cancer.
OUTLINE: Patients undergo blood sample collection before and after discontinuation of
fentanyl citrate therapy (10 days total). Pharmacokinetic analysis is performed on the
samples.
|
| Criteria: |
|
DISEASE CHARACTERISTICS:
- Diagnosis of cancer
- Inpatient at the Johns Hopkins Hospital Cancer Center undergoing pain treatment with
continuous infusion fentanyl citrate for ≥ 5 days
PATIENT CHARACTERISTICS:
- Willing to change to an alternative opioid
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- At least 72 hours since transdermal fentanyl citrate administration
- At least 12 hours since transmucosal fentanyl citrate administration
- No known requirement for continued opioid therapy with any fentanyl citrate products
after discontinuation of fentanyl citrate therapy
|
| NCT ID: |
|
NCT00899951 |
| Primary Contact: |
|
Principal Investigator Stuart A. Grossman, MD Sidney Kimmel Comprehensive Cancer Center
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Baltimore, Maryland 21231 United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 23, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|